Atossa Therapeutics Issues Letter to Shareholders
SEATTLE, Jan. 09, 2024 -- Atossa Therapeutics, Inc. , a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a focus...
Source: marketscreener.com